Can a New CFO Transform Edesa Biotech’s Fortune?
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer starting May 1, 2025, to enhance drug development efforts for immuno-inflammatory diseases. Weiler brings extensive pharmaceutical experience, previously holding key…